Article
ABCB1, SLC22A1, COMT, and OPRM1 genotypes: Study of their influence on plasma methadone levels and clinical response to methadone maintenance treatment in opioid use disorder.
Fundamental & clinical pharmacology - 1 Jun 2025
Ait Tayeb Abd El Kader, Laforgue Edouard-Jules, Schreck Benoit, Grall-Bronnec Marie, Hardouin Jean-Benoit, Leboucher Juliette, Victorri-Vigneau Caroline, Verstuyft Céline
Abstract excerpt
BACKGROUND: Opioid use disorder (OUD) is an emerging and global public health concern, and its management remains inadequate, notably due to a lack of biomarkers, except for the CYP2B6 genetic polymorphisms. OBJECTIVES: Hence, the aim of this study was to assess the influence of genetic polymorphisms of ABCB1, SLC22A1, COMT, and OPRM1 on biological parameters and clinical response in patients receiving methadone...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
